Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 371
Filtrar
2.
Asian J Psychiatr ; 98: 104105, 2024 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-38861790

RESUMO

Although there is considerable evidence showing that the prevention of mental illnesses and adverse outcomes and mental health promotion can help people lead better and more functional lives, public mental health remains overlooked in the broader contexts of psychiatry and public health. Likewise, in undergraduate and postgraduate medical curricula, prevention and mental health promotion have often been ignored. However, there has been a recent increase in interest in public mental health, including an emphasis on the prevention of psychiatric disorders and improving individual and community wellbeing to support life trajectories, from childhood through to adulthood and into older age. These lifespan approaches have significant potential to reduce the onset of mental illnesses and the related burdens for the individual and communities, as well as mitigating social, economic, and political costs. Informed by principles of social justice and respect for human rights, this may be especially important for addressing salient problems in communities with distinct vulnerabilities, where prominent disadvantages and barriers for care delivery exist. Therefore, this Commission aims to address these topics, providing a narrative overview of relevant literature and suggesting ways forward. Additionally, proposals for improving mental health and preventing mental illnesses and adverse outcomes are presented, particularly amongst at-risk populations.

4.
J Psychosom Res ; 181: 111664, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38652978

RESUMO

OBJECTIVE: Fibromyalgia syndrome (FMs) is a chronic, musculoskeletal pain disorder characterized by sleep disturbances, fatigue, and cognitive dysfunction. Heart rate variability biofeedback (HRV-BF) aiming to improve self-regulation and strengthen the parasympathetic nervous system has been shown to be effective in several pain syndromes, but its efficacy in FMs has not been adequately investigated. This Phase II trial aimed to assess the feasibility and preliminary measurement of the improvement induced by HRV-BF in FMs. METHODS: Sixty-four patients with FMs were recruited. Patients were randomly assigned to either the experimental group (EG) or the control group (CG). The EG received 10 HRV-BF training sessions in addition to pharmacological standard therapy. The CG received standard therapies for 10 weeks. The FMs impact on daily life, sleep regularity, sense of coherence, depression symptoms and pain has been assessed as primary outcomes, quality of life as secondary. RESULT: 23 (71.9%) of EG patients completed the intervention and 20 (62.5%) of the CG were re-evaluated at time T1. No side effects were reported. It was not found any statistical differences between groups over time in primary and secondary outcomes. CONCLUSIONS: The HRV-BF intervention did not demonstrate efficacy in both primary and secondary outcomes. However, it is quite feasible in terms of drop-out rate and side effects. Further studies with larger sample sizes are needed to determine its actual efficacy. CLINICALTRIALS: gov with code: NCT04121832.


Assuntos
Biorretroalimentação Psicológica , Fibromialgia , Frequência Cardíaca , Transtornos do Sono-Vigília , Humanos , Fibromialgia/terapia , Fibromialgia/fisiopatologia , Feminino , Frequência Cardíaca/fisiologia , Pessoa de Meia-Idade , Biorretroalimentação Psicológica/métodos , Transtornos do Sono-Vigília/terapia , Transtornos do Sono-Vigília/fisiopatologia , Adulto , Masculino , Qualidade de Vida , Resultado do Tratamento
6.
J R Soc Med ; : 1410768241244618, 2024 Apr 25.
Artigo em Inglês | MEDLINE | ID: mdl-38661443
7.
J R Soc Med ; : 1410768241244619, 2024 Apr 25.
Artigo em Inglês | MEDLINE | ID: mdl-38661444
8.
Int J Soc Psychiatry ; 70(3): 413-414, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38624166
9.
J R Soc Med ; 117(4): 131-133, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38497511
10.
13.
J R Soc Med ; 117(3): 102-103, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38381491
14.
Asian J Psychiatr ; 93: 103943, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38342035

RESUMO

Historically, doctors have migrated for a range of personal, educational, economic, and political reasons. Likewise, medical students from many countries have moved abroad to complete their training and education and may or may not return to their country of origin. Within this context, globalisation has had a major impact on medical education and healthcare workforces, contributing to recent migration trends. Globalisation is a complex phenomenon with positive and negative outcomes. For example, lower-income countries are regularly losing doctors to higher-income areas, thereby exacerbating strains on existing services. Across various national healthcare settings, migrating International Medical Graduates (IMGs) can face socioenvironmental and psychosocial pressures, which can lead to lower mental wellbeing and undermine their contributions to clinical care. Rates of stress and burnout are generally increasing for doctors and medical students. For IMGs, stressors related to migration, acculturation, and adjustment are not dissimilar to other migrants but may carry with them specific nuances. Accordingly, this Commission will explore the history of IMG trends and the challenges faced by IMGs, proposing recommendations and solutions to support their mental health and wellbeing.


Assuntos
Médicos , Psiquiatria , Humanos , Médicos Graduados Estrangeiros , Saúde Mental , Pessoal de Saúde
15.
J R Soc Med ; 117(2): 85-86, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38381500
18.
Int J Soc Psychiatry ; 69(7): 1549-1550, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37978853
19.
Schizophr Res ; 260: 168-179, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-37669576

RESUMO

BACKGROUND: Previous studies have shown mixed evidence on ethnic disparities in antipsychotic prescribing among patients with psychosis in the UK, partly due to small sample sizes. This study aimed to examine the current state of antipsychotic prescription with respect to patient ethnicity among the entire population known to a large UK mental health trust with non-affective psychosis, adjusting for multiple potential risk factors. METHODS: This retrospective cohort study included all patients (N = 19,291) who were aged 18 years or over at their first diagnoses of non-affective psychosis (identified with the ICD-10 codes of F20-F29) recorded in electronic health records (EHRs) at the South London and Maudsley NHS Trust until March 2021. The most recently recorded antipsychotic treatments and patient attributes were extracted from EHRs, including both structured fields and free-text fields processed using natural language processing applications. Multivariable logistic regression models were used to calculate the odds ratios (OR) for antipsychotic prescription according to patient ethnicity, adjusted for multiple potential contributing factors, including demographic (age and gender), clinical (diagnoses, duration of illness, service use and history of cannabis use), socioeconomic factors (level of deprivation and own-group ethnic density in the area of residence) and temporal changes in clinical guidelines (date of prescription). RESULTS: The cohort consisted of 43.10 % White, 8.31 % Asian, 40.80 % Black, 2.64 % Mixed, and 5.14 % of patients from Other ethnicity. Among them, 92.62 % had recorded antipsychotic receipt, where 24.05 % for depot antipsychotics and 81.72 % for second-generation antipsychotic (SGA) medications. Most ethnic minority groups were not significantly different from White patients in receiving any antipsychotic. Among those receiving antipsychotic prescribing, Black patients were more likely to be prescribed depot (adjusted OR 1.29, 95 % confidence interval (CI) 1.14-1.47), but less likely to receive SGA (adjusted OR 0.85, 95 % CI 0.74-0.97), olanzapine (OR 0.82, 95 % CI 0.73-0.92) and clozapine (adjusted OR 0.71, 95 % CI 0.6-0.85) than White patients. All the ethnic minority groups were less likely to be prescribed olanzapine than the White group. CONCLUSIONS: Black patients with psychosis had a distinct pattern in antipsychotic prescription, with less use of SGA, including olanzapine and clozapine, but more use of depot antipsychotics, even when adjusting for the effects of multiple demographic, clinical and socioeconomic factors. Further research is required to understand the sources of these ethnic disparities and eliminate care inequalities.


Assuntos
Antipsicóticos , Clozapina , Transtornos Psicóticos , Humanos , Antipsicóticos/uso terapêutico , Olanzapina/uso terapêutico , Clozapina/uso terapêutico , Etnicidade , Estudos Retrospectivos , Grupos Minoritários , Transtornos Psicóticos/tratamento farmacológico , Eletrônica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA